Ramautarsing, Reshmie A <br/><br/>
Thai HIV-1-infected women do not require a dose increase of lopinavir/ritonavir during the third trimester of pregnancy.  [electronic resource] 

 -  AIDS (London, England)  Jun 2011 
 - 1299-303 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-5571 
<br/><br/><label>Standard No.: </label>10.1097/QAD.0b013e328347f7e9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiretroviral Therapy, Highly Active<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>HIV Infections--drug therapy<br/>HIV-1--drug effects<br/>Humans<br/>Infectious Disease Transmission, Vertical--prevention & control<br/>Lopinavir<br/>Pregnancy<br/>Pregnancy Complications, Infectious--drug therapy<br/>Pregnancy Outcome<br/>Pregnancy Trimester, Third<br/>Pyrimidinones--administration & dosage<br/>RNA, Viral--drug effects<br/>Ritonavir--administration & dosage<br/>Viral Load